Eos SENOLYTIX
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9511 Collins 01403 Ave,Website
www.eossenolytix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Eos SENOLYTIX
Eos SENOLYTIX is a longevity company specializing in the development of novel gerotherapeutics aimed at improving healthspan and increasing lifespan by targeting the biological processes underlying aging. Utilizing advanced technologies and proprietary gerotherapeutic peptides, the company has demonstrated the ability to rejuvenate aged cells and enhance mitochondrial function. Founded in Houston, TX in 2017, Eos SENOLYTIX focuses on creating breakthrough therapies for chronic age-related diseases, including cancer and diabetes. Their innovative approach has resulted in the establishment of several affiliates dedicated to specific areas of longevity medicine.Explore more
Popular SearchesEos SENOLYTIXSIC Code 28,283NAICS Code 32,325Show moreEos SENOLYTIX Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Eos SENOLYTIX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Eos SENOLYTIX had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Eos SENOLYTIX has recently received funding, and reach out quickly before it becomes old news!
Eos SENOLYTIX, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Eos SENOLYTIX has new funding data
Check out if Eos SENOLYTIX is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Eos SENOLYTIX
Earning: See what the market has to say on Eos SENOLYTIX recently announced quarterly report
Product Launch: Get notified when Eos SENOLYTIX launches new products
Recommended Actions
Reach out to Masked Content who joined Eos SENOLYTIX as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Eos SENOLYTIX is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Eos SENOLYTIX is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Eos SENOLYTIX.
Eos SENOLYTIX financials insights
Gather financial insights about Eos SENOLYTIX, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Stock/Share Issuance
$750K
Eos SENOLYTIX News & Media
Eos SENOLYTIX Presents Best-in-Class Preclinical Body Composition Data Highlighting Unique Muscle Mass Gains with MitoXcel™ Geropeptide PTC-2105 at the Sachs 2nd Annual Obesity & Cardiometabolic Innovation Forum
Multi-System Improvements in Healthspan with PTC-2105 Treatment Translate into Associated Significant Increases in Cancer-Specific and Overall Survival Multi-System Improvements in Healthspan with PTC-2105 Treatment Translate into Associated Significant Increases in Cancer-Specific and Overall SurvivalPulmatrix Announces First Quarter 2026 Financial Results
Announced merger agreement with Eos SENOLYTIX in March Closed private placement of preferred stock FRAMINGHAM, Mass., May 15, 2026 /PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix" or the "Company") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel...Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger
/PRNewswire/ -- Pulmatrix, Inc. ("Pulmatrix" or the "Company") (Nasdaq: PULM), today announced the closing of its previously announced private placement of...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Eos SENOLYTIX
Sign Up For FreeTo access detailed company insights
Eos SENOLYTIX is a longevity company specializing in the development of novel gerotherapeutics aimed at improving healthspan and increasing lifespan by targeting the biological processes underlying aging. Utilizing advanced technologies and proprietary gerotherapeutic peptides, the company has demonstrated the ability to rejuvenate aged cells and e... Read More
